19-32598287-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_032139.3(ANKRD27):āc.3011A>Gā(p.Glu1004Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000917 in 1,614,078 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_032139.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ANKRD27 | NM_032139.3 | c.3011A>G | p.Glu1004Gly | missense_variant | 29/29 | ENST00000306065.9 | NP_115515.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ANKRD27 | ENST00000306065.9 | c.3011A>G | p.Glu1004Gly | missense_variant | 29/29 | 1 | NM_032139.3 | ENSP00000304292.3 | ||
ANKRD27 | ENST00000587667.1 | n.*41A>G | downstream_gene_variant | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000986 AC: 15AN: 152190Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 250972Hom.: 0 AF XY: 0.00000737 AC XY: 1AN XY: 135674
GnomAD4 exome AF: 0.0000910 AC: 133AN: 1461888Hom.: 0 Cov.: 30 AF XY: 0.0000839 AC XY: 61AN XY: 727246
GnomAD4 genome AF: 0.0000986 AC: 15AN: 152190Hom.: 0 Cov.: 33 AF XY: 0.0000807 AC XY: 6AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 03, 2024 | The c.3011A>G (p.E1004G) alteration is located in exon 29 (coding exon 28) of the ANKRD27 gene. This alteration results from a A to G substitution at nucleotide position 3011, causing the glutamic acid (E) at amino acid position 1004 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at